Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $94.75.

ACHC has been the subject of a number of analyst reports. Mizuho boosted their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a research note on Wednesday, March 6th. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. Barclays initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, March 6th. They set an “overweight” rating and a $100.00 target price for the company. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Finally, TD Cowen boosted their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research note on Friday, March 1st.

Insider Buying and Selling

In related news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.80% of the company’s stock.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Campbell & CO Investment Adviser LLC raised its holdings in shares of Acadia Healthcare by 177.4% in the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 7,357 shares of the company’s stock worth $517,000 after purchasing an additional 4,705 shares in the last quarter. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $24,157,000. Louisiana State Employees Retirement System acquired a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $2,014,000. Phocas Financial Corp. acquired a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $6,887,000. Finally, Raymond James Financial Services Advisors Inc. raised its holdings in shares of Acadia Healthcare by 109.3% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 44,300 shares of the company’s stock valued at $3,445,000 after acquiring an additional 23,138 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $70.16 on Friday. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a fifty-two week low of $66.49 and a fifty-two week high of $87.77. The firm has a 50-day simple moving average of $79.18 and a 200 day simple moving average of $77.62. The company has a market cap of $6.48 billion, a PE ratio of -280.63, a P/E/G ratio of 2.07 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. During the same quarter in the prior year, the firm earned $0.70 EPS. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Acadia Healthcare will post 3.57 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.